Creating for Tomorrow - a New Concept Car
Asahi Kasei and GLM, an electric vehicle manufacturer, have completed a jointly developed concept car called AKXY showcasing a wide array of automotive-related materials and technologies from various Asahi Kasei businesses, focused on contribution to safety, comfort, and the environment.
Discussions and planning for the development of the concept car began in 2015. The car utilizes the electric vehicle platform of GLM to achieve a drivable design. The concept car has a design based on the SUV.
AKXY contains a variety of Asahi Kasei materials, components and systems. The car is also equipped with cutting-edge technology that has potential for commercialization in line with automotive industry trends for safe driving and accident prevention.
“We are very excited to unveil this concept car that embodies Asahi Kasei’s comprehensive capability to serve the automotive industry with innovative, high-value products. We believe it will spark many conversations with key customers on how we can help them enhance the safety, comfort, and environmental performance of their future vehicles.” – Hiroshi Yoshida, Senior Executive Officer
most read
Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.
ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.
ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.
Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma
Part 3: Seven Theses for successful Digitalization in Pharma
Relocation of Chemicals Production Footprint in Full Swing
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.